CoreeGroup chooses Italy to study a probiotic that enhances the immune response

Coree Italy’s commitment to the study of new natural enhancers of mucosal vaccinations CoreeGroup chooses Italy to study a probiotic that enhances the immune response The new preparation will be studied, in particular, to be combined as a “booster” to mucosal vaccination, a form of vaccine administration such as that using nasal sprays or oral drops that offers many advantages: […]

Coree Pohang announce the DX24 App

Coree Pohang, a provider of digital healthcare solutions, recently announced that its remote medical service for Koreans living abroad, known as DX24, has obtained temporary authorization from the 1st Industry Convergence Regulatory Special Deliberation Committee this year. The Ministry of Trade, Industry, and Energy presented Coree Pohang with the original copy of the temporary permit on the 25th. DX24 is […]

Ofmom partecipates in Policlinico Kids

We are pleased to announce our participation in the fourth edition of Policlinico Kids (organized by the Italian Society of Paediatrics) to be held from 24 to 25 May at the University of Milan in Via Festa del Perdono 7. We look forward to meeting you to discuss the infant microbiota and introduce you to the Ofmom line.  

Ofmom participates in Vitafoods Europe 2023

We are pleased to announce our presence at Vitafoods Europe 2023, the global nutraceutical event that annually attracts over 25,000 industry experts from over 130 countries. Vitafoods Europe will take place at Palexpo in Geneva, from 9 to 11 May, and you can come and discover the Ofmom world at stand L250/5. All those who are interested in meeting us […]

Ofmom participates in the 12th edition of the congress “La pediatria nella pratica clinica”

From 2 to 4 February, the twelfth edition of the ‘Paediatrics in Clinical Practice’ congress was held at the Palazzo delle stelline in Milan. A 3-day event where we had the opportunity to talk to doctors, pediatricians, and health professionals about the changes that have characterized relationships with families in recent years and to present them with SYNTERACT™ BIMBI 14 […]

Global Vaccine Hub「KHUB Science Park」Full-scale Promotion in Pohang City

– Hanmi Pharmaceutical President, Lim Chong-yoon, established a public interest foundation for a global standard vaccine research and production facility in Pohang City. – Pohang city is expected to grow as a center for bio/vaccine/healthcare research and production. Pohang City announced that KHUB Science Park, which is a non-profit public interest research foundation led by the president of Hanmi Pharmaceutical […]

Hanmi Pharm Set to Produce COVID-19 Treatment for Merck and Supply to Developing Countries

Hanmi Pharmaceutical is set to manufacture a generic drug of Merck’s oral COVID-19 treatment drug and supply it to underdeveloped countries. On January 20th, Hanmi Pharmaceutical announced that it has recently signed a production agreement with the Medicines Patent Pool (MPP) for granting the right to produce molnupiravir (brand name: Lagevrio) developed by Merck of the United States. Under this […]

Hanmi Pharm Set to Produce DNA-based COVID-19 Vaccine Developed by Zydus Cadila

Hanmi Pharmaceutical announced that it would begin the production of ZyCoV-D, the COVID-19 plasmid DNA vaccine, developed by Indian pharmaceutical company Zydus Cadila (Zydus). To this end, Hanmi Pharm signed a contract for the technology transfer and facility preparation for consignment manufacturing of the ZyCoV-D vaccine with Enzychem Life Sciences on January 7. Enzychem signed a technology transfer agreement with […]

Chong Yoon Lim, CEO of Hanmi Science, announces addition of eWorldwide Group to Hanmi Science Consortium and invites other groups to join

As G20 Explores Vaccine Equity, Hanmi Science Consortium Pushes Forward with Vaccine Equity Initiative. In his recent opening address to the G20, Italian Prime Minister Mario Draghi highlighted vaccine inequity, emphasizing the fact that only 3% of eligible people living in the world’s poorest nations had received any form of COVID-19 vaccine, versus more than 70% in high-income countries. Mr. […]

Hanmi Pharmaceutical Makes Turnaround in Second Quarter with 120% Growth in Sales

Hanmi Pharmaceutical’s growth momentum continued with its operating profit climbing 49.6% in the second quarter. Beijing Hanmi Pharmaceutical, which had taken a severe blow from COVID-19, successfully achieved a turnaround with its sales rising 119.9% year-over-year. Hanmi Pharmaceutical posted a temporary notice stating that it achieved EUR 0.2 billion in sales, EUR 11.6 million in operating profit, and EUR 0.6 […]

Korea National Institute of Health (KNIH) conducts field inspection of companies with mRNA technology

Korea National Institute of Health (KNIH), Korea’s top research center in the field of hygiene and medicine (with Mr. Kwon Jun-Wook as President) conducted a field inspection of key companies with mRNA technology.   KNIH visited Hanmi Fine Chemical which is a company specializing in raw materials, which is a subsidiary of Hanmi Pharmaceutical Group and specializes in pharmaceutical products […]

1 Billion Doses a Year – It Will Become an Outpost for the Consigned Production of a Covid-19 Vaccine

Image Source: Hanmi Bio Plant   It was confirmed that global pharmaceutical companies developing Covid-19 vaccines have tried to reach Hanmi Pharm., as the production capability of Hanmi Bio Plant has drawn much attention.   “At the Hanmi Bio Plant, it is possible to produce annually the vaccine of a maximum of 1 billion doses. It could play a major […]

US FDA Designates Fast Track for Hanmi Pharm’s “LAPS Triple Agonist”

According to Hanmi Pharm, the US Food and Drug Administration (FDA) has designated LAPS Triple Agonist (HM15211), an innovative drug for the treatment of NASH (non-alcoholic steatohepatitis) manufactured by Hanmi, as a Fast Track drug. FDA generally designates the drug as “fast track” drugs when considering it must be developed quickly after the careful examination of new drugs with good […]

Babies and Covid19: the pharmaceutical giant COREE donates 150 thousand euros to 5 Italian hospitals.

Babies and Covid 19, only a few cases, but immediately on the front pages of newspapers. Coree, a giant in the Korean pharmaceutical sector and leader in Asia in the field of neonatal care, has decided to support the pediatricians of 5 Italian hospitals during the emergency. In a few days Coree, the Italian branch of Hanmi Pharmaceutical in Seoul, which […]

Chongyoon Lim’s Representative Departed to China and Italy to Unveil the “Second Act” of Hanmi Pharm’s Development

Chongyoon Lim, the representative of Hanmi Science who started the cause of “total health care”, developed new drugs in China, explored targeted medical and health cooperation, and expanded relevant businesses in Italy. On November 25, representative Chongyoon Lim of Hanmi Science listened to In-seon Lee, director of Daegu-Gyeongbuk Free Economic Zone, explaining the support plan at the business contract ceremony […]